BlackRock Health Sciences Term Trust (NYSE:BMEZ – Get Free Report) was the recipient of a significant decrease in short interest in July. As of July 31st, there was short interest totaling 60,925 shares, a decrease of 42.0% from the July 15th total of 105,031 shares. Based on an average daily trading volume, of 120,769 shares, the days-to-cover ratio is currently 0.5 days.
Institutional Investors Weigh In On BlackRock Health Sciences Term Trust
Large investors have recently added to or reduced their stakes in the business. Kestra Advisory Services LLC bought a new position in BlackRock Health Sciences Term Trust in the 4th quarter worth about $26,000. SouthState Bank Corp purchased a new position in shares of BlackRock Health Sciences Term Trust during the first quarter worth about $29,000. PNC Financial Services Group Inc. bought a new position in shares of BlackRock Health Sciences Term Trust in the first quarter worth approximately $35,000. Geneos Wealth Management Inc. bought a new position in shares of BlackRock Health Sciences Term Trust in the first quarter worth approximately $40,000. Finally, CWM LLC raised its stake in BlackRock Health Sciences Term Trust by 25.6% in the fourth quarter. CWM LLC now owns 3,336 shares of the company’s stock valued at $50,000 after purchasing an additional 680 shares in the last quarter.
BlackRock Health Sciences Term Trust Price Performance
NYSE:BMEZ traded up $0.25 during mid-day trading on Tuesday, hitting $16.27. 132,578 shares of the stock traded hands, compared to its average volume of 215,328. The business’s 50-day moving average price is $15.31 and its 200 day moving average price is $14.76. BlackRock Health Sciences Term Trust has a 12-month low of $13.70 and a 12-month high of $16.29.
BlackRock Health Sciences Term Trust Announces Dividend
About BlackRock Health Sciences Term Trust
BlackRock Health Sciences Term Trust (NYSE: BMEZ) is a closed-end management investment company organized as a Delaware statutory trust. Launched in March 2020, BMEZ seeks to provide total return through a combination of current income and capital appreciation by investing primarily in equity and equity-related securities of companies in the health sciences sector. The trust is structured with a fixed termination date in October 2030, at which time shareholders will vote on its liquidation, extension or conversion.
The fund’s investment portfolio is diversified across subsectors within health sciences, including biotechnology, pharmaceuticals, medical devices, diagnostics and healthcare services.
See Also
- Five stocks we like better than BlackRock Health Sciences Term Trust
- The AI Boom Is Turning This Cable Maker Into a Stock to Watch
- A Star Investor Just Trimmed Amazon—Here’s What It means
- Wendy’s Deal Buzz May Give Fast-Food Investors a New Reason to Look
- Home Depot Analysts See a Path to $375 and Beyond
Receive News & Ratings for BlackRock Health Sciences Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Health Sciences Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.
